Reach Us +44-1904-929220
Practicing Precision Surgical Pathology To Explore Clinically Meaningful Biomarkers For Personalized Oncology | 8897

Journal of Molecular Biomarkers & Diagnosis
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Practicing precision surgical pathology to explore clinically meaningful biomarkers for personalized oncology

4th International Conference on Biomarkers & Clinical Research

Hua Zhong

ScientificTracks Abstracts: J Mol Biomark Diagn

DOI: 10.4172/2155-9929.S1.017

Technical innovations, such as the high-throughput and highly efficient next-generation sequencing (NGS), hold the promise for improving cancer management through better understanding of cancer biology and the discoveries of new biomarkers significant for personalized oncology. However, how surgical pathology practice facilitates, collaborates with and nourishes from the new process is a big challenge. Precision surgical pathology, defined by the speaker as a core and indispensable component of personalized oncology, is a precise process that incorporates detailed gross denotations, bio-specimen repository, quality control, histological and molecular classifications, oncogenomics, clinical-histological-molecular-genomic correlations, and oncological epidemiology. Practicing precision surgical pathology in the setting of personalized oncology is able to identify putative, diagnostic, therapeutically actionable, rarely occurring and unexpected bio-genomic markers that are clinically meaningful. Selected cases of such a practice will be presented and discussed.
Hua Zhong is a practicing surgical Pathology and a member of the Cancer Institute of New Jersey
Relevant Topics